SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data

-CT

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection (NOCOVID)

-clinicaltrials.gov

The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 began on January 11th at Ashford and St Peter’s Hospitals NHS Foundation Trust, in Surrey

-Research at the Trust

UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19

-BusinessWire

SaNOtize Ramps Up Anti-COVID Nasal Spray Production To Keep Up With Demand

-Bloomberg